Acetylcysteine USP
Composition : Mukof Tablet : Each Dispersible Tablet Contains Acetylcysteine USP 600mg.
Indications : It is indicated
as an adjunctive treatment for patients with abnormal, viscid or inspissated
mucus secretions associated with conditions such as
· Acute and
chronic bronchopulmonary disorders (e.g. pneumonia, bronchitis, emphysema,
tracheobronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis,
primary amyloidosis of the lung)
· Atelectasis
caused by mucus obstruction
· Pulmonary
complications of cystic fibrosis
· Pulmonary
complications of thoracic and cardiovascular surgery &
· Post-traumatic
chest conditions. It is effective in all respiratory airways disease causing
formation of a dense secretion that cannot be or can only partially be expectorated
such as acute and chronic bronchitis, laryngitis, sinusitis, tracheitis,
influenza & bronchial asthma. Acetylcysteine is also indicated in the
treatment of Paracetamol overdose. Treatment option is optimal if given within
8 hours of Paracetamol ingestion.
Dosage
and administration : Adults & children above 6 years of age: 1 tablet daily
(Preferably in the evening). The duration of treatment should be
5-10 days in acute treatment. In Paracetamol overdose: Initially
140 mg/kg, followed by 70 mg/kg every 4 hours for an additional 17
doses. Dissolve 1 tablet in a glass of water (200 ml) to drink. Or, as
directed by the registered physician.
Use in Pregnancy and lactation: Pregnancy category B. Caution should be taken in case of pregnancy & lactation while using Acetylcysteine.
